A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that the diagnostic caught the neurodegenerative disease in 100% of the… Read More
University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million Series B funding round. The funding will help propel the… Read More
A $40.5 million collaborative research center headquartered at Seattle’s Allen Institute aims to create high-resolution maps of brains ravaged by Alzheimer’s disease, to trace new paths to early diagnosis and… Read More
The University of Washington, UC Berkeley and UC San Francisco are launching a research network aimed at finding new treatments for brain diseases. Dubbed the Weill Neurohub, the effort is… Read More
The University of Washington is putting a $50 million philanthropic donation toward a new institute that will research and develop treatments for brain disorders. Called the Institute for Brain Health… Read More
If you want a glimpse at medicine’s track record against Alzheimer’s, look no further than the numbers: Pharmaceutical companies have recorded a 99 percent failure rate against the disease, spending… Read More
Researchers at the University of Washington have created a molecule that aims to stop the formation of protein clusters thought to be a prime contributor to Alzheimer’s disease. In a… Read More
The richest people in the world are putting some of their fortunes toward finding a better way to diagnose Alzheimer’s disease. Bill Gates and Jeff and MacKenzie Bezos are backing… Read More
Medical researchers know all about the blood-brain barrier, but Seattle’s Allen Institute and the American Heart Association have selected three teams to participate in a $43 million initiative to study… Read More
Today’s featured stories Prime Day tops 100M products sold, becomes ‘biggest shopping event in Amazon history,’ despite glitches Investors including Bill Gates put $30M towards Alzheimer’s ‘venture philanthropy’ initiative Ex-Amazon… Read More
Alzheimer’s disease is both common and devastating. A predicted 14 million Americans will have the disease by 2050 and it is already the sixth biggest killer in the country. Despite… Read More
What do babies and startups have in common? “When you think everything is perfect, the next day something happens,” said Leen Kawas, CEO and president of Seattle’s M3 Biotechnology —… Read More
The Institute for Systems Biology is taking a swing at one of the most widespread and puzzling diseases in the United States: Alzheimer’s. ISB along with Seattle startup Arivale, both… Read More
Alzheimer’s remains one of the biggest puzzles in the medical world. It’s a devastating disease that impacts millions of people across the globe, but there are no treatments that can… Read More
The University of Washington’s Alzheimer’s Disease Research Center received a $6 million donation from the Ellison Foundation to boost its efforts to find new treatments for the degenerative brain disease, the… Read More